반응 #221

ord-e45b32fa63b1416c9334b4592b5aba03

반응 방정식

CN1CCc2cccc(Nc3cc(Cl)ncc3Cl)c2C1=O
CN1CCc2cccc(Nc3cc(Cl
Cn1nccc1N
Cn1nccc1N
CN1CCc2cccc(Nc3cc(Nc4ccnn4C)ncc3Cl)c2C1=O
CN1CCc2cccc(Nc3cc(Nc
수율 26.9%

용매

반응 조건

온도
100°CELSIUS

실험 절차

8-(2,5-dichloropyridin-4-ylamino)-2-methyl-3,4-dihydroisoquinolin-1(2H)-one (100 mg, 0.31 mmol), 1-methyl-1H-pyrazol-5-amine (60.3 mg, 0.62 mmol), sodium 2-methylpropan-2-olate (44.7 mg, 0.47 mmol), 2,2'-bis(diphenylphosphino)-1,1'-binaphthyl (38.7 mg, 0.06 mmol) and TRIS(DIBENZYLIDENEACETONE)DIPALLADIUM (28.4 mg, 0.03 mmol) were suspended in dioxane (2 mL) and sealed into a tube. The reaction was degased, purged with nitrogen and heated to 100 °C for 1 hour. Reaction was filtered, washed with CH2Cl2 and concentrated to dryness. The reaction mixture was purified by preparative HPLC using a Waters X-Bridge reverse-phase column (5 microns silica, 30 mm diameter, 150 mm length) and decreasingly polar mixtures of water (containing 0.2% ammonium carbonate) and acetonitrile as eluent. The fractions were evaporated to dryness to afford 8-(5-chloro-2-(1-methyl-1H-pyrazol-5-ylamino)pyridin-4-ylamino)-2-methyl-3,4-dihydroisoquinolin-1(2H)-one (32.0 mg, 26.9 %) as a white solid.

출처

750 AstraZeneca ELN dataset